Target intelligence / Profile preview

Biorientation of chromosomes in cell division protein 1 (BOD1)

Target
BOD1
Molecular classification
Other, Kinetochore protein, Phosphatase inhibitor
01

Overview

Biorientation of chromosomes in cell division protein 1 (BOD1) is a small, conserved protein crucial for the accurate segregation of chromosomes during mitosis[1][4][6]. BOD1 localizes to spindle poles and kinetochores, where it plays an essential role in the establishment of correct microtubule–kinetochore attachments, ensuring sister chromatid biorientation and cohesion during cell division[1][4]. Its molecular function includes the inhibition of the protein phosphatase 2A (PP2A)–B56 complex, a key regulator of kinetochore substrate dephosphorylation[3][6]. Loss of BOD1 leads to defects such as syntelic microtubule attachments, elongated spindles, improper chromosome alignment, cohesion loss, and premature chromatid separation, resulting in genomic instability and eventual cell death[1][3][4][6]. While BOD1 is not currently considered a direct therapeutic target or a receptor/enzyme/transporter, its depletion or dysfunction can contribute to disease states, particularly cancers associated with chromosomal instability.

Other names
Biorientation defective 1FAM44BProtein FAM44BBiorientation defective protein 1Family with sequence similarity 44 member B
02

Biological functions

Chromosome biorientationMitotic chromatid cohesionSpindle organizationChromosome segregation
03

Disease associations

Cancer (by implication, due to its role in mitotic fidelity and chromosomal instability)
04

Safety considerations

Chromosomal instability and aneuploidy upon deficiencyPotential for mitotic defects and cell death when depleted

Beyond the preview

Go deeper on Biorientation of chromosomes in cell division protein 1 (BOD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biorientation of chromosomes in cell division protein 1 (BOD1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call